Reuters
01 Jun 2026, 10:34 UTC · 16w ago
Verdict
Headline leans bullish. We score BONE −1.00 across two claims.
Score contradicts the headline.
Leans bullish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
2 claims · scored −1 bearish … +1 bullish
Summit Therapeutics' ivonescimab therapy showed a 15% improvement in overall survival for advanced lung cancer patients compared to BeOne Medicines' Tevimbra.
So whatSuperior survival data in a major oncology indication is a primary catalyst for stock price appreciation and potential market share dominance.
More positive than 99% of claims this week
Summit Therapeutics' shares rose as much as 7% in pre-market trading following the data release.
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 64% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
Its immunotherapy drug Tevimbra was outperformed by a competitor's therapy in terms of patient survival.
More positive than 99% of ticker scores this week
Shares rose after clinical data showed its therapy helped patients live longer than a competitor's product.
More positive than 99% of ticker scores this week
Partner in the successful ivonescimab therapy trial results.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
8h ago
More positive than 57% of relationship scores this week
[mutual] Ivonescimab therapy from Summit Therapeutics competes with BeOne Medicines' Tevimbra for lung cancer patients.
—
No price for BONE right now — the quote feed didn't answer.
BONE chart →
